Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

NCT00307723 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

52

Enrollment

OTHER

Sponsor class

Stopped poor accrual

Conditions

Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: bevacizumab
DRUG: 5-Fluorouracil
DRUG: Oxaliplatin
DRUG: gemcitabine
PROCEDURE: External Beam Radiation Therapy

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]